Cluster 791865
green
· 149 citation events
across 13 courts.
Showing the 29 strongest citers on record
(one row per citing case, strongest signal kept).
See Ind. Mich., 422 F.3d at 1378 (“In the case of the continuing contractual obligations owed after an initial suit for partial breach has been filed, subsequent claims [for future damages are considered to] accrue for the purposes of statute of limitations at the time such damages are incurred.”)- The APSA’s language limiting Con Ed’s retained claims to those accrued “prior to closing” had the effect of assigning away all claims that accrued on or after the sale, including …
“In the case of the continuing contractual obligations owed after an initial suit for partial breach has been filed, subsequent claims [for future damages are considered to] accrue for the purposes of statute of limitations at the time such damages are incurred.”
Compare Symbol Techs., 422 F.3d at 1385 (“refiling an application solely containing previously-allowed claims for the business purpose of delaying their issuance can be considered an abuse of the patent system”).
“refiling an application solely containing previously-allowed claims for the business purpose of delaying their issuance can be considered an abuse of the patent system”
green
Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co. (2007)
Cf. Symbol III, 422 F.3d at 1385 (“[Rjefiling an application solely containing previously-allowed claims for the business purpose of delaying their issuance can be considered an abuse of the patent system.”).
“[Rjefiling an application solely containing previously-allowed claims for the business purpose of delaying their issuance can be considered an abuse of the patent system.”
green
Seagen Inc. v. Daiichi Sankyo Co., Ltd. (2022)
Found., LP, 422 F.3d 1378 , 1385 (Fed.
“Symbol II”
The district court first decided that under Symbol Technologies, Inc. v. Lemelson Medical, 422 F.3d 1378 (Fed.
“Sym- bol Techs. II”
green
Apple Inc. v. Itc (2026)
Cir. 2005). “[A]n exam- ination of the totality of the circumstances, including the prosecution history of all of a series of related patents and overall delay in issuing claims, may trigger laches.” Id. at 1386.
green
Hyatt v. Vidal (2024)
One example of reasonable pre-filing delay is “filing a divisional application in response to a restriction requirement, even if the filing occurs immediately before issuance of the parent application.” Hyatt II, 998 F.3d at 1361–62 (citing Symbol II, 422 F.3d at 1385).
green
Natera, Inc. v. ArcherDX, Inc. (2023)
Cir. 2005), courts should weigh the totality of the circumstances as a matter of equity to determine the reasonableness of prosecution, see id. at 1386.
green
Hyatt v. Matal (2022)
The first prong requires the kind of delay demonstrating an “egregious case[] of misuse of the statutory patent system.” Symbol Techs., 422 F.3d at 1385.
green
Hyatt v. Matal (2018)
I, 422 F.3d at 1386.
green
Hyatt v. Iancu (2018)
II , 422 F.3d at 1382, 1384 , with Woodbridge , 263 U.S. at 56 -62 , 44 S.Ct. 45 (discussing indicia of deliberateness, willfulness, and intent).
green
Hyatt v. Lee (2017)
To determine whether a delay is unreasonable and unexplained, courts conduct “an examination of the totality of the circumstances, including the prosecution history of all of a series of related patents and overall delay in issuing claims.” Id. at 1386.
green
Medtronic, Inc. v. Boston Scientific Corp. (2011)
The matter is to be decided as a matter of equity, subject to the discretion of a district court before which the issue is raised.” Id. at 1385.
green
Centocor Ortho Biotech, Inc. v. Abbott Laboratories (2009)
Australia Pty., Ltd. v. Int’l Game Tech., 543 F.3d 657 , 664 n. 4 (Fed.Cir.2008) (citing Symbol, 422 F.3d at 1385, and noting that “prosecution irregularities” is distinct from “prosecution laches” and that “[p]rosecution laches stems not from any procedural lapse or irregularity during prosecution, but rather from an abuse of statutory provisions that results, as a matter of equity, in an unreasonable and unexplained delay in prosecution.”).
green
Ormco Corp. v. ALIGN TECHNOLOGY, INC. (2009)
The doctrine should be applied only in egregious cases of misuse of the statutory patent system.” Symbol III, 422 F.3d at 1385.
green
Tafas v. Doll (2009)
However, it is limited to cases of "unreasonable and unexplained delay in prosecution." Id. at 1384-85.
green
Honeywell International Inc. v. United States (2008)
In making this determination, the court should examine “the totality of the circumstances, including the prosecution history of all of a series of related patents and overall delay in issuing claims.” Id. at 1386.
green
Tafas v. Dudas (2007)
This sentiment is supported by Symbol Techs., Inc. v. Lemelson Med., Educ. & Research Found., 422 F.3d 1378 (Fed.Cir.2005("Symbol IV”), where the Federal Circuit held that the doctrine of *665 prosecution laches “should be used sparingly lest statutory provisions be unjustifiably vitiated.” Id. at 1385.
Prosecution laches is a doctrine that is to “be applied only in egregious cases of misuse of the statutory patent system.” Id. at 1385.
green
Southern Nuclear Operating Co. v. United States (2007)
Accordingly, Indiana Michigan must bring any future actions for damages related to DOE’s breach of the Standard Contract within six years of incurring such damages.” 422 F.3d at 1378.
green
Novozymes A/S v. Genencor International, Inc. (2006)
Prosecution laches “should be applied only in egregious cases of misuse of the statutory patent system.” Symbol, 422 F.3d at 1385.
The court emphasized that the doctrine of prosecution laches should be used “sparingly” and only in “egregious cases of misuse of the statutory patent system.” Id. at 1384-85.
The opinion is amended by amending the last sentence of page 13 [422 F.3d at 1386] to read “We therefore affirm the district court’s holding of unenforceability as to the 76 asserted claims.” The following new paragraphs are also added after the last sentence of page 13: — Although the district court did not make its resolution of the laches issue applicable to the remaining claims, holding that the question would be decided only if it later became necessary to do so, in our…
green
Baltimore v. Clinton (2012)
See id.
See Symbol II, 422 F.3d at 1382 (citing intervening rights as additional factual considerations); see also In re Bogese II, 303 F.3d 1362, 1367 (Fed.Cir.2002) (affirming Board of Patent Appeal’s forfeiture of patent based upon prosecution laches without requirement of intervening rights); see also Reiffin v. Microsoft Corp., 270 F.Supp.2d 1132, 1154 (N.D.Cal.2003) (“the demonstration of unreasonable and unexplained delay [is] the sole element of the defense of prosecution la…
See Symbol II, 422 F.3d at 1382 (citing intervening rights as additional factual considerations); see also In re Bogese II, 303 F.3d 1362, 1367 (Fed.
See Symbol II, 422 F.3d at 1382 (citing intervening rights as additional factual considerations); see also In re Bogese II, 303 F.3d 1362, 1367 (Fed. *1113 Cir.2002) (affirming Board of Patent Appeal's forfeiture of patent based upon prosecution laches without requirement of intervening rights); Reiffin v. Microsoft Corp., 270 F.Supp.2d 1132, 1154 (N.D.Cal. 2003) ("the demonstration of unreasonable and unexplained delay [is] the sole element of the defense of prosecution lac…
green
Personalized Media Communications, LLC v. Apple Inc. (2023)
See Hyatt, 998 F.3d at 1362; see also Symbol Techs., 422 F.3d at 1385 (ex- plaining that actions taken “for the business purpose of de- laying [] issuance can be considered an abuse of the patent system”).
ex- plaining that actions taken “for the business purpose of de- laying [] issuance can be considered an abuse of the patent system”